Publication | Open Access
A double-blind, placebo-controlled, randomized withdrawal trial of sarilumab for the treatment of glucocorticoid-dependent sarcoidosis
15
Citations
24
References
2023
Year
ClinicalTrials.gov, http://clinicaltrials.gov, NCT04008069.
| Year | Citations | |
|---|---|---|
Page 1
Page 1